Department of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada B3H 1X5.
Virology. 2010 Feb 5;397(1):119-29. doi: 10.1016/j.virol.2009.10.039. Epub 2009 Nov 20.
The reovirus fusion-associated small transmembrane (FAST) proteins evolved to induce cell-cell, rather than virus-cell, membrane fusion. It is unclear whether the FAST protein fusion reaction proceeds in the same manner as the enveloped virus fusion proteins. We now show that fluorescence-based cell-cell and cell-RBC hemifusion assays are unsuited for detecting lipid mixing in the absence of content mixing during FAST protein-mediated membrane fusion. Furthermore, membrane curvature agents that inhibit hemifusion or promote pore formation mediated by influenza hemagglutinin had no effect on p14-induced cell-cell fusion, even under conditions of limiting p14 concentrations. Standard assays used to detect fusion intermediates induced by enveloped virus fusion proteins are therefore not applicable to the FAST proteins. These results suggest the possibility that the nature of the fusion intermediates or the mechanisms used to transit through the various stages of the fusion reaction may differ between these distinct classes of viral fusogens.
呼肠孤病毒融合相关小跨膜(FAST)蛋白的进化目的是诱导细胞-细胞融合,而不是病毒-细胞融合。FAST 蛋白融合反应是否与包膜病毒融合蛋白以相同的方式进行尚不清楚。我们现在表明,基于荧光的细胞-细胞和细胞-RBC 半融合测定不适合检测在 FAST 蛋白介导的膜融合过程中没有内容混合的情况下的脂质混合。此外,抑制半融合或促进流感血凝素介导的孔形成的膜曲率试剂对 p14 诱导的细胞-细胞融合没有影响,即使在限制 p14 浓度的条件下也是如此。因此,用于检测包膜病毒融合蛋白诱导的融合中间产物的标准测定不适用于 FAST 蛋白。这些结果表明,融合中间产物的性质或用于通过融合反应的各个阶段的机制在这些不同类别的病毒融合剂之间可能不同。